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Hemophagocytic lymphohistiocytosis (HLH) is an unusual and rare syndrome characterized by fever, splenomegaly, pancytopenia, and the 
pathologic finding of hemophagocytosis (phagocytosis 
by macrophages of erythrocytes, leukocytes, platelets, 
and their precursors) in bone marrow and other tissues. 
HLH comprises two different forms, a primary1,2 and 
a secondary form.1,3 The primary autosomal recessive 
form, familial hemophagocytic lymphohistiocytosis 
(FHLH), is a fatal disease with a median survival of less 
than 2 months after diagnosis if untreated, and typically 
has its onset during infancy or early childhood. Family 
history is often negative since the disease is recessive. 
Importantly, the onset of FHL and bouts of the disease 
may be triggered by infections.2,4,5 Secondary HLH 
(sHLH) may develop as a result of strong immunologi-
cal activation of the immune system, which may, for ex-
ample, be caused by a severe infection. sHLH has been 
described in immunocompromized hosts in association 
with viral or bacterial infections, virus (infection) asso-
ciated hemophagocytic syndrome (VAHS,or IAHS).3,6 
sHLH may also develop during malignancies (malig-
nancy-associated hemophagocytic syndrome, MAHS). 
It may be the presenting clinical picture and mask an 
underlying malignancy, or it may develop during the 
treatment for a known malignancy.3,4 We report a series 
of three cases of HLH diagnosed in our institution rep-
resenting three different facets of HLH-FHLH, IAHS 
and MAHS. These three cases illustrate the diversity of 
this syndrome and highlight the possibility of a treat-
able cause for a sHLH.
CASE 1
A 7-year-old male child was admitted with intermit-
tent high-grade fever and painful abdomen for previ-
ous 2 months along with episodes of gum bleeding for 
the previous 15 days. There was no significant family 
history or past medical history. On clinical examination 
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the child was febrile, had pallor, purpuric spots all over 
and the gums were bleeding. The vital parameters were 
within normal limits. Abdominal examination showed 
hepatosplenomegaly. There was no lymphadenopathy 
or sternal tenderness. Investigations showed a hemo-
globin of 8 gm/dL, a total leukocyte count of 2200 
cells/mm3 and a platelet count of 40 000 cells/mm3, in-
dicating pancytopenia. The differential count for white 
blood cells was normal. The peripheral blood smear was 
within normal limits with no abnormal cells or para-
sites. All routine investigations were non-contributory. 
Ultrasound of the abdomen confirmed hepatospleno-
megaly with no lymph node enlargement. Chest x-ray 
and coagulation profile were within normal limits. 
Bone marrow aspiration showed a hypercellular mar-
row with the presence of numerous histiocytes engulf-
ing erythroid cells, neutrophils, lymphocytes and plate-
lets leading to a suspicion of HLH (Figures 1, 2). Bone 
marrow culture showed no growth. Serum ferritin (684 
mcg/L) was high, fibrinogen (84.6 mg/dL) was low 
and fasting serum triglyceride (350mg/dL) was high, 
confirming the diagnosis of HLH. Blood culture, HIV 
serology, Weil-Felix test, Widal test and rK39 test were 
negative. HBsAg and ANA were negative. Anti-Epstein 
B virus IgM was negative. A diagnosis of FHLH was 
made. The patient was given supportive therapy, but 
died on the seventh day of admission before any deci-
sion on chemotherapy could be taken.
CASE 2
A 40-year-old grossly malnourished female presented 
with continuous low grade fever, painful abdomen and 
weight loss for the previous 3 months. Clinical examina-
tion showed a firm non-tender splenomegaly with mild 
hepatomegaly. Chest x-ray showed patchy infiltrates in 
the apical portion of the right lung. Abdominal ultra-
sound revealed hepatosplenomegaly with mild ascites. 
A complete blood count showed hemoglobin of 8.5%, 
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a total leukocyte count of 1800 cells/mm3 and a plate-
let count of 70 000 cells/mm3, indicating pancytopenia. 
The peripheral blood smear was normal. Other investi-
gations were within normal limits. A Mantoux test with 
5 TU showed an induration of 20 cm (positive). Blood 
culture and sputum smears and culture were non-con-
tributory. A bone marrow biopsy showed hypercellular 
marrow with evidence of haemophagocytosis (Figure 
3). A few scattered epithelioid cell collections were also 
seen (Figure 4). Bone marrow culture showed growth of 
Mycobacterium tuberculosis. A diagnosis of IAHS sec-
ondary to tuberculosis was considered. The serum fer-
ritin was high (1423 µg/L), fasting serum triglyceride 
(459 mg/dL) was high and fibrinogen (134 mg/dL) was 
low confirming the diagnosis. The patient was started 
on a four-drug anti-tubercular therapy for 6 months. 
He had a remarkable recovery with pancytopenia com-
pletely resolving within 5 weeks of treatment. 
CASE 3
A 52-year-old male presented with high-grade fever, 
weight loss and an erythematous rash over the face and 
chest. He had hepatosplenomegaly and generalized 
lymphadenopathy. Investigations revealed pancytopenia 
(hemoglobin, 5.2 g%, a total leucocyte count 600 cells/
mm3, a platelet count of 52 000/mm3) and markedly 
elevated liver enzymes, particularly alkaline phospha-
tase (974 U/L). Serum lactate dehydrogenase was 566 
U/L. A lymph node biopsy showed sheets of atypical 
large, pleomorphic cells with hyperchromatic, irregular 
nuclei, and scant cytoplasm, reminiscent of lymphoid 
cells (Figure 5). These cells were also seen within the 
cytoplasm of macrophages. On immunohistochemis-
try, the atypical lymphoid cells were positive for CD3 
and negative for CD20, leading to a diagnosis of diffuse 
non-Hodgkins lymphoma of the T-cell type. Bone mar-
row examination was done to evaluate persistent pan-
cytopenia, which showed hemophagocytosis of formed 
blood cells along with evidence of lymphoma infiltra-
tion (Figure 6). A final diagnosis of HLH secondary 
to T-cell lymphoma was made. The patient was treated 
with chemotherapy under CHOP (cyclophosphamide, 
hydroxydaunomycin, vincristine, and prednisone) pro-
tocol with supportive measures. He responded to ther-
apy and pancytopenia, which improved after the first 
cycle. However, the patient expired during the second 
cycle due to sepsis-related complications.
DISCUSSION
These three cases of HLH illustrate three different fac-
ets of HLH. All patients presented with fever, hepato-
splenomegaly and pancytopenia. In the first case HLH 
was confirmed by bone marrow examination and rel-
evant investigations. Most of the investigations as per 
HLH protocol were done during the short hospital stay 
of the patient and were normal. We consider this to be 
a case of primary HLH (FHLH). However, the possi-
bility of other viral infections could not be ruled out as 
only EBV serology was done. We were able to conclude 
tuberculosis to be the cause of secondary HLH in the 
second case. The growth of Mycobacterium tuberculosis in 
Figure 1. Bone marrows smear showing macrophage engulfing 
polymorphs (wright stain, 1000×).
Figure 2. Bone marrow smear showing phagocytosis of erythoid 
precursors and polymorphs (wright Stain, 1000×).
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the bone marrow culture, the presence of epithelioid cell 
collection in the marrow and the response to anti-tuber-
cular therapy provided conclusive evidence. Tuberculosis 
is already known to be a cause of sHLH and we con-
cluded it to be a case of IAHS due to tuberculosis. 
The third case had lymphpadenopathy, which pro-
vided diagnostic help. Lymph node histopathology led 
to a diagnosis of diffuse non-Hodgkins lymphoma of 
the T-cell type. Bone marrow examination showed 
hemophagocytosis along with lymphoma infiltration. 
Various lymphomas, including cutaneous T-cell lym-
phomas, T/NK cell lymphomas are commonly asso-
ciated with HLH.3,4 Therefore, a diagnosis of MAHS 
due to T-cell lymphoma was made.
HLH is a severe systemic inflammatory reaction 
characterized by uncontrolled activation and prolif-
Figure 3. Bone marrow smear showing erythro phagocytosis 
(wright stain, 1000×).
Figure 4. Bone marrow smear showing collection of epitheloid 
cells (wright stain, 1000×).
Figure 5. Lymph node smear showing showing sheets of atypical 
large, pleomorphic cells with hyperchromatic, irregular nuclei, 
and scant cytoplasm suggestive of diffuse NHL (H&e, 400×).
Figure 6. Bone marrow smear showing hemophagocytosis and 
lymphoma cell infilration (wright stain, 1000×).
eration of macrophages and T cells with multiorgan 
infiltration and dysfunction. Hemophagocytosis is the 
pathognomic feature of HLH. Different causative or-
ganisms are viruses (Epstein-Barr virus, cytomegalovi-
rus, adenovirus) bacteria (Mycobacterium tuberculosis, 
Pseudomonas aeruginosa) fungi (Histoplasma capsulatum, 
Candida spp) and parasites (L donovani). HLH appears 
to affect all ages, although the hereditary and sporadic 
cases are reported primarily in children.2,5 A seasonal 
pattern has been suggested, in which cases occur more 
often in the summer. 
The diagnosis of HLH is often difficult due to 
the rarity of the disease and lack of a specific labora-
tory test, resulting in underdiagnosis. In an attempt to 
overcome these difficulties, the FHL study group of the 
Histiocytic Society has proposed diagnostic guidelines 
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for HLH.1,8 Clinical criteria include clinical, laboratory, 
and histopathologic features. Fever and splenomegaly 
are the most common clinical signs, but hepatomegaly, 
lymphadenopathy, jaundice, and rash are also seen. The 
most prominent laboratory abnormalities noted are cy-
topenias, which may be profound. Serum chemistry find-
ings may suggest hemolysis, with hyperbilirubinemia and 
elevation of lactate dehydrogenase. Most patients have 
hypertriglyceridemia and marked elevation of ferritin.1 
Serum fibrinogen is typically low, and there may be dis-
seminated intravascular coagulation. Elevated circulating 
fibrin degradation products and serum ferritin in patients 
with HLH appear to be associated with an increased risk 
for death. Histopathologically, hemophagocytosis is seen 
in bone marrow, spleen, and lymph nodes8 and occasion-
ally the central nervous system and skin. Activated mac-
rophages may engulf erythrocytes, leukocytes, and plate-
lets, their precursors, and cellular fragments. These cells 
appear “stuffed” with other blood cells.
Treatment is based on the HLH-2004 protocol.1,7 
It is designed for the patients with HLH, with or with-
out evidence of familial or genetic disease and regard-
less of suspected or documented viral infections. Initial 
therapy (weeks 1-8) is based on etoposide, dexametha-
sone and cyclosporin A (CSA). Only selected patients 
receive intrathecal therapy with methotrexate and pred-
nisolone. In patients without a known family history 
who achieve complete resolution of the disease after 8 
weeks of therapy, treatment is stopped to avoid hema-
topoietic stem cell transplantation (HSCT) in a child 
that may have sHLH. All children with familial disease 
or with a diagnosis verified by genetic testing, as well as 
children with a non-familial disease that is severe and 
persistent, or reactivated, are recommended to receive 
continuation therapy with etoposide, dexamethasone, 
and cyclosporin. HSCT should be performed as early 
as possible when an acceptable donor is available. The 
complete protocol is available on request at www.histio.
org/society/protocols.
In conclusion, HLH should be considered in the 
differential diagnosis of unexplained cases of fever, 
splenomegaly and pancytopenia. It may be associated 
with malignancy or any infectious illnesses, including 
sepsis, tuberculosis and viral infections. Knowledge of 
this is important as HLH may mask malignant or in-
fectious disease and may be the first presenting sign. 
Treatment of the underlying infection will also result 
in resolution of HLH.
1. Henter ji, Horne a, arico M, egeler RM, Filipo-
vich aH, imashuku S, Ladisch S, McClain K, webb 
D, winiarski j, janka G. HLH-2004: Diagnostic 
and Therapeutic Guidelines for Hemophagocytic 
Lymphohistiocytosis. Pediatr Blood Cancer 2007; 
48:124-131.
2. Henter ji, arico M, elinder G. Familial hemo-
phagocytic lymphohistiocytosis (primary HLH). 
Hematol Oncol Clin North am 1998; 12:417-433.
3. janka G, elinder G, imashuku S, Schneider M, 
Henter ji. infection- and malignancy associated 
hemophagocytic syndromes: Secondary hemo-
phagocytic lymphohistiocytosis. Hematol Oncol 
Clin North am 1998; 12:435-444.
4. Chang CS, wang CH, Su ij, Chen YC, Shen MC. 
Hematophagic histiocytosis: a clinicopathologic 
analysis of 23 cases with special reference to the 
association with peripheral T-cell lymphoma. j 
Formos Med assoc 1994; 93:421-8.
5. janka Ge. Familial hemophagocytic lymphohis-
tiocytosis. eur j Pediatr 1983;140:221-230.
6. Risdall Rj, McKenna Rw, Nesbit Me, Krivit w, 
Balfour HH jr, Simmons RL, Brunning RD. Virus-
associated hemophagocytic syndrome. a benign 
histiocytic proliferation distinct from malignant 
histiocytosis. Cancer 1979;44:993-1002
7. janka Ge, Schenider eM. Modern management 
of children with haemophagocytic lymphohistio-
cytosis. Br j Haematol 2004;124:4-14.
8. Henter ji, elinder GO. The FHL Study Group of 
the Histiocyte Society. Diagnostic guidelines for 
hemophagocytic lymphohistiocytosis. Semin On-
col 1991; 18:29-33.
REFERENCES
